Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma

被引:0
作者
Stephan Herberhold
Martin Hellmich
Marcus Panning
Eva Bartok
Steffi Silling
Baki Akgül
Ulrike Wieland
机构
[1] University of Bonn,ENT Department, Head and Neck Surgery
[2] Johanniter-Kliniken Bonn,ENT Department
[3] University of Cologne,Institute of Medical Statistics, Informatics and Epidemiology
[4] Medical Center – University of Freiburg,Institute for Virology
[5] University of Bonn,Institute of Clinical Chemistry and Clinical Pharmacology
[6] University of Cologne,Institute of Virology, National Reference Center for Papilloma
来源
Medical Microbiology and Immunology | 2017年 / 206卷
关键词
Human polyomavirus; Human papillomavirus; Tonsillitis; Tonsillar hyperplasia; Tonsillar carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
Human papillomaviruses (HPVs) are an acknowledged cause of a subset of oropharyngeal cancers, especially of tonsillar cancer. Similar to HPV, some human polyomaviruses (HPyVs), such as Merkel cell polyomavirus (MCPyV), have an oncogenic potential. Recently, several novel HPyVs have been discovered. The aim of our study was to determine viral DNA prevalence and viral DNA load of 13 different HPyVs in benign and malignant tonsillar tissue and to compare the data with those found for HPV. A total of 78 biopsies of palatine tonsils with a histologic diagnosis of non-malignant disease (chronic tonsillitis, tonsillar hyperplasia, n = 40) or tonsillar squamous cell carcinoma (n = 38) were included in the study. HPyV DNA prevalence and viral load were determined by virus-specific quantitative real-time PCRs. JCPyV (1/40, 2.5%) and WUPyV (3/40, 7.5%) were only found in non-malignant tonsillar tissue. HPyV7 and HPyV10 were only detected in one (2.6%) and seven (18.4%) of the 38 cancer biopsies, respectively. Both MCPyV (8/38, 21.1 vs. 4/40, 10.0%) and HPyV6 (2/38, 5.3 vs. 1/40, 2.5%) were found more frequently in cancer samples than in non-malignant tissue, but the differences were not significant. BKPyV, KIPyV, TSPyV, HPyV9, STLPyV, HPyV12 and NJPyV were not discovered in any of the samples. HPyV loads found in HPyV DNA-positive biopsies were very low with no difference between non-malignant and malignant samples (median load <0.0001 HPyV DNA copies per beta-globin gene copy, respectively). In contrast to HPyV, high-risk HPV types (HPV16/HPV18) were found significantly more frequently in tonsillar cancers than in non-malignant tonsillar tissue (17/38, 44.7 vs. 2/40, 5.0%, p < 0.001). Furthermore, high-risk HPV DNA loads were significantly higher in the cancer compared to the non-malignant samples (median load 11.861 vs. 7 × 10−6 HPV DNA copies per beta-globin gene copy, p = 0.012). While both HPV and HPyV may persist in tonsillar tissue, our data on HPyV DNA prevalence and load do not support a role of HPyV in tonsillar carcinogenesis, neither alone nor as co-infecting agents of HPV.
引用
收藏
页码:93 / 103
页数:10
相关论文
共 573 条
  • [1] Gillison ML(2015)Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma J Clin Oncol 33 3235-3242
  • [2] Chaturvedi AK(2015)HPV and cancer of the oral cavity Virulence 6 244-248
  • [3] Anderson WF(2015)Increase in head and neck cancer in younger patients due to human papillomavirus (HPV) Oral Oncol 51 727-730
  • [4] Fakhry C(2016)The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer Laryngoscope 126 894-900
  • [5] Hübbers CU(2014)HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis Lancet Oncol 15 1319-1331
  • [6] Akgül B(2014)The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation Otolaryngol Head Neck Surg 151 375-380
  • [7] Young D(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2893-2917
  • [8] Xiao CC(2008)Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 261-269
  • [9] Murphy B(2016)Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 phase III registration trial for patients with locoregionally advanced oropharyngeal squamous cell carcinoma of the head and neck treated with radiotherapy with or without cetuximab J Clin Oncol 34 1300-1308
  • [10] Moore M(2015)Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence Eur J Cancer 51 514-521